[1]
N. Rahayu, E. Elvioza, and A. Kekalih, “Comparison of Visual Acuity and Central Macular Thickness in Neovascular Age-related Macular Degeneration Patients with Subretinal and Intraretinal Fluid Treated with Intravitreal Bevacizumab”, OI, vol. 45, no. 1, p. 20, Apr. 2019, doi: 10.35749/journal.v45i1.173.